These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 1835747

  • 1. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Cassatella MA, Trentin L, Bulian P, Siviero F, Feruglio C, Agostini C, Vespignani M, Chisesi T, Pizzolo G.
    Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Facco M, Trentin L, Sancetta R, Tassinari C, Perin A, Milani A, Pizzolo G, Rodeghiero F, Agostini C, Meazza R, Ferrini S, Semenzato G.
    Blood; 1997 Jan 01; 89(1):201-11. PubMed ID: 8978293
    [Abstract] [Full Text] [Related]

  • 3. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes.
    Zambello R, Trentin L, Pizzolo G, Bulian P, Masciarelli M, Feruglio C, Agostini C, Raimondi R, Chisesi T, Semenzato G.
    Blood; 1990 Nov 15; 76(10):2080-5. PubMed ID: 2146981
    [Abstract] [Full Text] [Related]

  • 4. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Trentin L, Cassatella MA, Raimondi R, Cerutti A, Enthammer C, Facco M, Agostini C, Semenzato G.
    Br J Haematol; 1996 Feb 15; 92(2):308-14. PubMed ID: 8602990
    [Abstract] [Full Text] [Related]

  • 5. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM.
    Cancer Res; 1990 May 01; 50(9):2683-91. PubMed ID: 1691679
    [Abstract] [Full Text] [Related]

  • 6. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
    Trentin L, Zambello R, Benati C, Cassatella M, Agostini C, Bulian P, Adami F, Carra G, Pizzolo G, Semenzato G.
    Cancer Res; 1992 Oct 01; 52(19):5223-8. PubMed ID: 1394125
    [Abstract] [Full Text] [Related]

  • 7. IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor.
    Jankovic DL, Rebollo A, Kumar A, Gibert M, Thèze J.
    J Immunol; 1990 Dec 15; 145(12):4136-44. PubMed ID: 2258612
    [Abstract] [Full Text] [Related]

  • 8. Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor.
    Yoon HJ, Sugamura K, Loughran TP.
    Leukemia; 1990 Dec 15; 4(12):848-50. PubMed ID: 2147047
    [Abstract] [Full Text] [Related]

  • 9. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction.
    Ortaldo JR, Mason AT, O'Shea JJ, Smyth MJ, Falk LA, Kennedy IC, Longo DL, Ruscetti FW.
    J Immunol; 1991 Jun 01; 146(11):3791-8. PubMed ID: 1851793
    [Abstract] [Full Text] [Related]

  • 10. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
    Foxwell BM, Simon J, Herrero JJ, Taylor D, Woerly G, Cantrell D, Ryffel B.
    Immunology; 1990 Jan 01; 69(1):104-9. PubMed ID: 2312149
    [Abstract] [Full Text] [Related]

  • 11. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R, Trentin L, Cerutti A, Enthammer C, Milani A, Franceschi T, Messina C, Cetto GL, Agostini C, Semenzato G.
    Cancer; 1994 Nov 01; 74(9):2562-9. PubMed ID: 7522954
    [Abstract] [Full Text] [Related]

  • 12. Role of tumor necrosis factor-alpha and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Trentin L, Bulian P, Cassatella M, Raimondi R, Chisesi T, Agostini C, Semenzato G.
    Blood; 1992 Oct 15; 80(8):2030-7. PubMed ID: 1327287
    [Abstract] [Full Text] [Related]

  • 13. Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor.
    Audrain M, Boeffard F, Soulillou JP, Jacques Y.
    J Immunol; 1991 Feb 01; 146(3):884-92. PubMed ID: 1988501
    [Abstract] [Full Text] [Related]

  • 14. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA, Ledbetter JA, Lee K, June CH, Thompson CB.
    J Immunol; 1990 Mar 01; 144(5):1646-53. PubMed ID: 2155264
    [Abstract] [Full Text] [Related]

  • 15. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
    Bayle C, Vitté-Mony I, Lang P, Pico J, Hercend T, Bertoglio J.
    Leukemia; 1992 May 01; 6(5):470-6. PubMed ID: 1375700
    [Abstract] [Full Text] [Related]

  • 16. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J.
    Eur J Immunol; 1992 Jan 01; 22(1):1-6. PubMed ID: 1370410
    [Abstract] [Full Text] [Related]

  • 17. Activation of the interleukin 2 pathway precedes CD3-T cell receptor expression in thymic development. Differential growth requirements of early and mature intrathymic subpopulations.
    Toribio ML, De la Hera A, Marcos MA, Márquez C, Martínez C.
    Eur J Immunol; 1989 Jan 01; 19(1):9-15. PubMed ID: 2522051
    [Abstract] [Full Text] [Related]

  • 18. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
    Vandenberghe P, Ceuppens JL.
    Eur J Immunol; 1991 Feb 01; 21(2):251-9. PubMed ID: 1705509
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
    Lorré K, Fransen L, Ceuppens JL.
    Eur Cytokine Netw; 1992 Feb 01; 3(3):321-30. PubMed ID: 1353987
    [Abstract] [Full Text] [Related]

  • 20. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
    Bjorndahl JM, Sung SS, Hansen JA, Fu SM.
    Eur J Immunol; 1989 May 01; 19(5):881-7. PubMed ID: 2544432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.